Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Start-Ups

STENTiT: Scaffolds Regenerate Arteries From the Inside Out

While the first generation of bioresorbable stents aims to enhance the treatment of peripheral artery disease with temporary support, STENTiT is on to the next generation with a platform of resorbable devices that promise to do what no stent can: elicit natural regeneration of the artery.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Perspective & Commentary

MedTech Strategist Top 5: October 2021

The five most-read MedTech Strategist articles posted in October to MyStrategist.com: ShangBay Capital's approach to medtech investing, Glenn Snyder and Paul Grand discuss findings from the recent MedTech Innovator/Deloitte survey on medtech start-up trends, highlights from NASS 2021, and near-term opportunities in the neural interface field.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More